GRCE
Grace Therapeutics, Inc. Common StockstockNASDAQ
At CloseNov 18, 2026 3:59:05 PM EST
1.72USD+1.176%(+0.02)99,127
Pre-marketNov 19, 2026 8:25:30 AM EST
1.7003USD-1.145%(-0.0197)
After-hoursNov 18, 2026 4:00:30 PM EST
1.73USD+0.581%(+0.01)
GRCE Financials
In Q2 FY 2027 (ended ), Grace Therapeutics, Inc. Common Stock (GRCE) reported net income of −$2.13M, operating cash flow of −$1.78M, and assets of $57.7M (filed ).
Loading financial statements…